Noile-Immune Biotech (TSE:4893) Other Long-Term Liabilities : 円5.2 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Other Long-Term Liabilities?

Noile-Immune Biotech's other long-term liabilities for the quarter that ended in Mar. 2024 was 円5.2 Mil.

Noile-Immune Biotech's quarterly other long-term liabilities increased from Sep. 2023 (円5.2 Mil) to Dec. 2023 (円5.2 Mil) but then stayed the same from Dec. 2023 (円5.2 Mil) to Mar. 2024 (円5.2 Mil).

Noile-Immune Biotech's annual other long-term liabilities declined from Dec. 2021 (円0.0 Mil) to Dec. 2022 (円0.0 Mil) but then increased from Dec. 2022 (円0.0 Mil) to Dec. 2023 (円5.2 Mil).

Noile-Immune Biotech Other Long-Term Liabilities Historical Data

The historical data trend for Noile-Immune Biotech's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Other Long-Term Liabilities Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial				-	-	-	-	-

Noile-Immune Biotech Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Noile-Immune Biotech Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines